SCHEMBL863081

SCHEMBL863081

CCN(CC)c1ccc(C(c2ccc(N(CC)CC)cc2)c2cc(S(=O)(=O)O)ccc2S(=O)(=O)O)cc1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HSP90AA1 P07900 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSHR P16473 1/20 0.40
CNR2 P34972 14/20 0.40
CNR1 P21554 5/20 0.39
GRK6 P43250 1/20 0.39
MAPT P10636 2/20 0.38
TP53 P04637 1/20 0.38
HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4019441 1.00 ALDH1A1 (0.41) ALDH1A1MEN1HPGDKMT2AL3MBTL1
SCHEMBL21176648 0.99 ALDH1A1 (0.40) ALDH1A1MEN1HPGDKMT2AL3MBTL1
SCHEMBL4020690 0.99 ALDH1A1 (0.40) ALDH1A1MEN1HPGDKMT2AL3MBTL1
SCHEMBL111712 0.90 ALDH1A1 (0.41) ALDH1A1MEN1HPGDKMT2AL3MBTL1
SCHEMBL25506725 0.87 ALDH1A1 (0.41) ALDH1A1MEN1HPGDKMT2AL3MBTL1
SCHEMBL10595694 0.84 CNR2 (0.43) ALDH1A1MEN1HPGDKMT2AL3MBTL1
SCHEMBL2107754 0.82 ALDH1A1 (0.44) ALDH1A1MEN1HPGDKMT2AL3MBTL1
SCHEMBL30487077 0.82 ALDH1A1 (0.44) ALDH1A1MEN1HPGDKMT2AL3MBTL1
SCHEMBL4019433 0.82 ALDH1A1 (0.44) ALDH1A1MEN1HPGDKMT2AL3MBTL1
SCHEMBL31244568 0.82 ALDH1A1 (0.44) ALDH1A1MEN1HPGDKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270168-A1 SYNTHESIS PROCESS FOR HIGH PURITY ISOSULFAN BLUE USING FLASH CHROMATOGRAPHY IN COMMERCIAL PLANT SCALE RISING PHARMA HOLDINGS, INC. (US) 2025-08-28 US claimed
EP-3997066-A1 METHOD FOR THE PREPARATION OF DIARYLMETHANE DYES AND TRIARYLMETHANE DYES INCLUDING ISOSULFAN BLUE NJ Biopharmaceuticals LLC (US) 2022-05-18 EP claimed
US-7534911-B2 Process for the preparation of Isosulphan Blue INNOVASSYNTH TECHNOLOGIES (INDIA) LTD. (IN) 2009-05-19 US claimed
US-20060224003-A1 A PROCESS FOR THE PREPARATION OF ISOSULPHAN BLUE RISING PHARMA HOLDINGS, INC. 2006-10-05 US claimed
CN-121850906-A Preparation method of isothioblue deethylation impurity 暨明医药科技(苏州)有限公司 2026-04-14 CN disclosed
US-20250270168-A1 SYNTHESIS PROCESS FOR HIGH PURITY ISOSULFAN BLUE USING FLASH CHROMATOGRAPHY IN COMMERCIAL PLANT SCALE RISING PHARMA HOLDINGS, INC. (US) 2025-08-28 US disclosed
US-12180142-B1 Synthesis process for high purity isosulfan blue using flash chromatography in commercial plant scale RISING PHARMA HOLDINGS, INC. (US) 2024-12-31 US disclosed
US-20230159444-A1 PROCESS FOR SYNTHESIZING SULFONATED TRIARYL METHANE COMPOUNDS PROVEPHARM LIFE SOLUTIONS (FR) 2023-05-25 US disclosed
US-20220289671-A1 METHOD FOR THE PREPARATION OF DIARYLMETHANE DYES AND TRIARYLMETHANE DYES INCLUDING ISOSULFAN BLUE NJ BIOPHARMACEUTICALS LLC (US) 2022-09-15 US disclosed
EP-3997066-A1 METHOD FOR THE PREPARATION OF DIARYLMETHANE DYES AND TRIARYLMETHANE DYES INCLUDING ISOSULFAN BLUE NJ Biopharmaceuticals LLC (US) 2022-05-18 EP disclosed
WO-2021011440-A1 METHOD FOR THE PREPARATION OF DIARLYMETHANE DYES AND TRIARYLMETHANE DYES INCLUDING ISOSULFAN BLUE NJ BIOPHARMACEUTICALS LLC (US) 2021-01-21 WO disclosed
US-20200347013-A1 PROCESS FOR PREPARATION OF ISOSULFAN BLUE APICORE US LLC (US) 2020-11-05 US disclosed
US-7662992-B2 Process for preparation of isosulfan blue APICORE, LLC (US) 2010-02-16 US disclosed
US-7534911-B2 Process for the preparation of Isosulphan Blue INNOVASSYNTH TECHNOLOGIES (INDIA) LTD. (IN) 2009-05-19 US disclosed
US-20080293963-A1 PROCESS FOR PREPARATION ISOSULFAN BLUE APICORE, LLC (US) 2008-11-27 US disclosed
US-20080293963-A1 PROCESS FOR PREPARATION ISOSULFAN BLUE APICORE, LLC (US) 2008-11-27 US disclosed
WO-2008140564-A1 PROCESS FOR PREPARATION OF ISOSULFAN BLUE APICORE, LLC (US) 2008-11-20 WO disclosed
US-20080281127-A1 PROCESS FOR PREPARATION OF ISOSULFAN BLUE APICORE, LLC (US) 2008-11-13 US disclosed
US-20080281127-A1 PROCESS FOR PREPARATION OF ISOSULFAN BLUE APICORE, LLC (US) 2008-11-13 US disclosed
US-20060224003-A1 A PROCESS FOR THE PREPARATION OF ISOSULPHAN BLUE RISING PHARMA HOLDINGS, INC. 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200347013-A1 PROCESS FOR PREPARATION OF ISOSULFAN BLUE SI, STS, MPST ALDH1A1 77/4885MEN1 3920/4885HPGD 993/4885
US-20250270168-A1 SYNTHESIS PROCESS FOR HIGH PURITY ISOSULFAN BLUE USING FLASH CHROMATOGRAPHY IN COMMERCIAL PLANT SCALE CBS, SLC6A12, RPS4Y1 ALDH1A1 1717/4885MEN1 2901/4885HPGD 3647/4885
US-20220289671-A1 METHOD FOR THE PREPARATION OF DIARYLMETHANE DYES AND TRIARYLMETHANE DYES INCLUDING ISOSULFAN BLUE TST, DDT, CYP2E1 ALDH1A1 372/4885MEN1 3006/4885HPGD 1074/4885
US-12180142-B1 Synthesis process for high purity isosulfan blue using flash chromatography in commercial plant scale CBS, SLC6A12, RPS4Y1 ALDH1A1 1717/4885MEN1 2901/4885HPGD 3647/4885
US-20080293963-A1 PROCESS FOR PREPARATION ISOSULFAN BLUE SI, STS, MPST ALDH1A1 70/4885MEN1 3995/4885HPGD 821/4885
US-20080281127-A1 PROCESS FOR PREPARATION OF ISOSULFAN BLUE SI, MPST, STS ALDH1A1 89/4885MEN1 4175/4885HPGD 982/4885
US-20230159444-A1 PROCESS FOR SYNTHESIZING SULFONATED TRIARYL METHANE COMPOUNDS SQOR, SULT1E1, TST ALDH1A1 445/4885MEN1 914/4885HPGD 2192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.